__________________________________________
Person subject to the notification requirement
Position: Closely associated person
(X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer
Position: Member of the Board
Issuer:
LEI: 7437008736AG7HY51K13
Notification type: INITIAL NOTIFICATION
Reference number: 48652/4/6
____________________________________________
Transaction date: 2024-01-03
Outside a trading venue
Instrument type: SHARE
ISIN: FI4000480454
Nature of transaction: ACQUISITION
Transaction details
(1): Volume: 606370 Unit price:
Aggregated transactions (1):
Volume: 606370 Volume weighted average price:
Further enquiries
Certified adviser:
Information about Bioretec
Bioretec is a globally operating Finnish medical device company that continues to pioneer the Bioretec is a globally operating Finnish medical device company that continues to pioneer the application of biodegradable orthopedic implants. The company has built unique competencies in the biological interface of active implants to enhance bone growth and accelerate fracture healing after orthopedic surgery. The products developed and manufactured by Bioretec are used worldwide in approximately 40 countries.
Bioretec is developing the new RemeOs(TM) product line based on a magnesium alloy and hybrid composite, introducing a new generation of strong biodegradable materials for enhanced surgical outcomes. The RemeOs(TM) implants are absorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing. The combination has the potential to make titanium implants redundant and help clinics reach their
Better healing - Better life. www.bioretec.com
https://news.cision.com/bioretec/r/bioretec-ltd---managers--transactions,c3904581
(c) 2024 Cision. All rights reserved., source